ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Immunoglobulins Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5T8288
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Rabies Immunoglobulins Market Insights Forecast to 2028
BUY CHAPTERS

Global Rabies Immunoglobulins Market Research Report 2025

Code: QYRE-Auto-5T8288
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Grifols S A
Sanofi
Kamada
Sichuan Yuanda Shuyang
Shuanglin Bio
Weiguang Bio
Shanghai Raas
Bharat Serum
Tiantan Bio
CBPO
VINS

Rabies Immunoglobulins Market Size

The global market for Rabies Immunoglobulins was valued at US$ 327 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Rabies Immunoglobulins Market

Rabies Immunoglobulins Market

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or povidone-iodine and is followed by a course of rabies vaccine. It is given by injection into the site of the wound and into a muscle. It is not needed in people who have been previously vaccinated against rabies.
The rising incidence of rabies, especially in developing countries, is a key driver of the rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for rabies immunoglobulin in both rural and urban areas.
A major challenge in the rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Immunoglobulins.
The Rabies Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rabies Immunoglobulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rabies Immunoglobulins Market Report

Report Metric Details
Report Name Rabies Immunoglobulins Market
Accounted market size in year US$ 327 million
Forecasted market size in 2031 US$ 407 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Category II Exposure
  • Category III Exposure
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, Tiantan Bio, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rabies Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rabies Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Rabies Immunoglobulins Market growing?

Ans: The Rabies Immunoglobulins Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Rabies Immunoglobulins Market size in 2031?

Ans: The Rabies Immunoglobulins Market size in 2031 will be US$ 407 million.

Who are the main players in the Rabies Immunoglobulins Market report?

Ans: The main players in the Rabies Immunoglobulins Market are CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, Tiantan Bio, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS

What are the Application segmentation covered in the Rabies Immunoglobulins Market report?

Ans: The Applications covered in the Rabies Immunoglobulins Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Rabies Immunoglobulins Market report?

Ans: The Types covered in the Rabies Immunoglobulins Market report are ERIG, HRIG

Recommended Reports

Rabies Immunology

Vaccine Adjuvants

Zoonotic Vaccines

1 Rabies Immunoglobulins Market Overview
1.1 Product Definition
1.2 Rabies Immunoglobulins by Type
1.2.1 Global Rabies Immunoglobulins Market Value Comparison by Type (2024 VS 2031)
1.2.2 ERIG
1.2.3 HRIG
1.3 Rabies Immunoglobulins by Application
1.3.1 Global Rabies Immunoglobulins Market Value by Application (2024 VS 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Rabies Immunoglobulins Market Size Estimates and Forecasts
1.4.1 Global Rabies Immunoglobulins Revenue 2020-2031
1.4.2 Global Rabies Immunoglobulins Sales 2020-2031
1.4.3 Global Rabies Immunoglobulins Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rabies Immunoglobulins Market Competition by Manufacturers
2.1 Global Rabies Immunoglobulins Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rabies Immunoglobulins Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rabies Immunoglobulins Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rabies Immunoglobulins, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rabies Immunoglobulins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immunoglobulins, Product Type & Application
2.7 Global Key Manufacturers of Rabies Immunoglobulins, Date of Enter into This Industry
2.8 Global Rabies Immunoglobulins Market Competitive Situation and Trends
2.8.1 Global Rabies Immunoglobulins Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rabies Immunoglobulins Players Market Share by Revenue
2.8.3 Global Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rabies Immunoglobulins Market Scenario by Region
3.1 Global Rabies Immunoglobulins Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rabies Immunoglobulins Sales by Region: 2020-2031
3.2.1 Global Rabies Immunoglobulins Sales by Region: 2020-2025
3.2.2 Global Rabies Immunoglobulins Sales by Region: 2026-2031
3.3 Global Rabies Immunoglobulins Revenue by Region: 2020-2031
3.3.1 Global Rabies Immunoglobulins Revenue by Region: 2020-2025
3.3.2 Global Rabies Immunoglobulins Revenue by Region: 2026-2031
3.4 North America Rabies Immunoglobulins Market Facts & Figures by Country
3.4.1 North America Rabies Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rabies Immunoglobulins Sales by Country (2020-2031)
3.4.3 North America Rabies Immunoglobulins Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immunoglobulins Market Facts & Figures by Country
3.5.1 Europe Rabies Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rabies Immunoglobulins Sales by Country (2020-2031)
3.5.3 Europe Rabies Immunoglobulins Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immunoglobulins Market Facts & Figures by Region
3.6.1 Asia Pacific Rabies Immunoglobulins Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rabies Immunoglobulins Sales by Region (2020-2031)
3.6.3 Asia Pacific Rabies Immunoglobulins Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rabies Immunoglobulins Market Facts & Figures by Country
3.7.1 Latin America Rabies Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rabies Immunoglobulins Sales by Country (2020-2031)
3.7.3 Latin America Rabies Immunoglobulins Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Immunoglobulins Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rabies Immunoglobulins Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rabies Immunoglobulins Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Immunoglobulins Sales by Type (2020-2031)
4.1.1 Global Rabies Immunoglobulins Sales by Type (2020-2025)
4.1.2 Global Rabies Immunoglobulins Sales by Type (2026-2031)
4.1.3 Global Rabies Immunoglobulins Sales Market Share by Type (2020-2031)
4.2 Global Rabies Immunoglobulins Revenue by Type (2020-2031)
4.2.1 Global Rabies Immunoglobulins Revenue by Type (2020-2025)
4.2.2 Global Rabies Immunoglobulins Revenue by Type (2026-2031)
4.2.3 Global Rabies Immunoglobulins Revenue Market Share by Type (2020-2031)
4.3 Global Rabies Immunoglobulins Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rabies Immunoglobulins Sales by Application (2020-2031)
5.1.1 Global Rabies Immunoglobulins Sales by Application (2020-2025)
5.1.2 Global Rabies Immunoglobulins Sales by Application (2026-2031)
5.1.3 Global Rabies Immunoglobulins Sales Market Share by Application (2020-2031)
5.2 Global Rabies Immunoglobulins Revenue by Application (2020-2031)
5.2.1 Global Rabies Immunoglobulins Revenue by Application (2020-2025)
5.2.2 Global Rabies Immunoglobulins Revenue by Application (2026-2031)
5.2.3 Global Rabies Immunoglobulins Revenue Market Share by Application (2020-2031)
5.3 Global Rabies Immunoglobulins Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Rabies Immunoglobulins Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Rabies Immunoglobulins Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Rabies Immunoglobulins Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Company Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sichuan Yuanda Shuyang Rabies Immunoglobulins Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 Tiantan Bio
6.5.1 Tiantan Bio Company Information
6.5.2 Tiantan Bio Description and Business Overview
6.5.3 Tiantan Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tiantan Bio Rabies Immunoglobulins Product Portfolio
6.5.5 Tiantan Bio Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Company Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kamada Rabies Immunoglobulins Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.7.1 CBPO Company Information
6.7.2 CBPO Description and Business Overview
6.7.3 CBPO Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CBPO Rabies Immunoglobulins Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Company Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shuanglin Bio Rabies Immunoglobulins Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Company Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Weiguang Bio Rabies Immunoglobulins Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Company Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai RAAS Rabies Immunoglobulins Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Company Information
6.11.2 Bharat Serum Description and Business Overview
6.11.3 Bharat Serum Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bharat Serum Rabies Immunoglobulins Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Company Information
6.12.2 VINS Description and Business Overview
6.12.3 VINS Rabies Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)
6.12.4 VINS Rabies Immunoglobulins Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Immunoglobulins Industry Chain Analysis
7.2 Rabies Immunoglobulins Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immunoglobulins Production Mode & Process Analysis
7.4 Rabies Immunoglobulins Sales and Marketing
7.4.1 Rabies Immunoglobulins Sales Channels
7.4.2 Rabies Immunoglobulins Distributors
7.5 Rabies Immunoglobulins Customer Analysis
8 Rabies Immunoglobulins Market Dynamics
8.1 Rabies Immunoglobulins Industry Trends
8.2 Rabies Immunoglobulins Market Drivers
8.3 Rabies Immunoglobulins Market Challenges
8.4 Rabies Immunoglobulins Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Behring
Grifols S A
Sanofi
Kamada
Sichuan Yuanda Shuyang
Shuanglin Bio
Weiguang Bio
Shanghai Raas
Bharat Serum
Tiantan Bio
CBPO
VINS
List of Tables
 Table 1. Global Rabies Immunoglobulins Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rabies Immunoglobulins Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rabies Immunoglobulins Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rabies Immunoglobulins Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rabies Immunoglobulins Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rabies Immunoglobulins Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rabies Immunoglobulins Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rabies Immunoglobulins Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rabies Immunoglobulins, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rabies Immunoglobulins, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rabies Immunoglobulins, Product Type & Application
 Table 12. Global Key Manufacturers of Rabies Immunoglobulins, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rabies Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immunoglobulins as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rabies Immunoglobulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rabies Immunoglobulins Sales by Region (2020-2025) & (M Units)
 Table 18. Global Rabies Immunoglobulins Sales Market Share by Region (2020-2025)
 Table 19. Global Rabies Immunoglobulins Sales by Region (2026-2031) & (M Units)
 Table 20. Global Rabies Immunoglobulins Sales Market Share by Region (2026-2031)
 Table 21. Global Rabies Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rabies Immunoglobulins Revenue Market Share by Region (2020-2025)
 Table 23. Global Rabies Immunoglobulins Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rabies Immunoglobulins Revenue Market Share by Region (2026-2031)
 Table 25. North America Rabies Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rabies Immunoglobulins Sales by Country (2020-2025) & (M Units)
 Table 27. North America Rabies Immunoglobulins Sales by Country (2026-2031) & (M Units)
 Table 28. North America Rabies Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rabies Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rabies Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rabies Immunoglobulins Sales by Country (2020-2025) & (M Units)
 Table 32. Europe Rabies Immunoglobulins Sales by Country (2026-2031) & (M Units)
 Table 33. Europe Rabies Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rabies Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rabies Immunoglobulins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rabies Immunoglobulins Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific Rabies Immunoglobulins Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific Rabies Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rabies Immunoglobulins Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rabies Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rabies Immunoglobulins Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America Rabies Immunoglobulins Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America Rabies Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rabies Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rabies Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rabies Immunoglobulins Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa Rabies Immunoglobulins Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa Rabies Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rabies Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rabies Immunoglobulins Sales (M Units) by Type (2020-2025)
 Table 51. Global Rabies Immunoglobulins Sales (M Units) by Type (2026-2031)
 Table 52. Global Rabies Immunoglobulins Sales Market Share by Type (2020-2025)
 Table 53. Global Rabies Immunoglobulins Sales Market Share by Type (2026-2031)
 Table 54. Global Rabies Immunoglobulins Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rabies Immunoglobulins Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rabies Immunoglobulins Revenue Market Share by Type (2020-2025)
 Table 57. Global Rabies Immunoglobulins Revenue Market Share by Type (2026-2031)
 Table 58. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rabies Immunoglobulins Sales (M Units) by Application (2020-2025)
 Table 61. Global Rabies Immunoglobulins Sales (M Units) by Application (2026-2031)
 Table 62. Global Rabies Immunoglobulins Sales Market Share by Application (2020-2025)
 Table 63. Global Rabies Immunoglobulins Sales Market Share by Application (2026-2031)
 Table 64. Global Rabies Immunoglobulins Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rabies Immunoglobulins Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rabies Immunoglobulins Revenue Market Share by Application (2020-2025)
 Table 67. Global Rabies Immunoglobulins Revenue Market Share by Application (2026-2031)
 Table 68. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Behring Rabies Immunoglobulins Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Rabies Immunoglobulins Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Rabies Immunoglobulins Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Sichuan Yuanda Shuyang Company Information
 Table 86. Sichuan Yuanda Shuyang Description and Business Overview
 Table 87. Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sichuan Yuanda Shuyang Rabies Immunoglobulins Product
 Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 90. Tiantan Bio Company Information
 Table 91. Tiantan Bio Description and Business Overview
 Table 92. Tiantan Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Tiantan Bio Rabies Immunoglobulins Product
 Table 94. Tiantan Bio Recent Developments/Updates
 Table 95. Kamada Company Information
 Table 96. Kamada Description and Business Overview
 Table 97. Kamada Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Kamada Rabies Immunoglobulins Product
 Table 99. Kamada Recent Developments/Updates
 Table 100. CBPO Company Information
 Table 101. CBPO Description and Business Overview
 Table 102. CBPO Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CBPO Rabies Immunoglobulins Product
 Table 104. CBPO Recent Developments/Updates
 Table 105. Shuanglin Bio Company Information
 Table 106. Shuanglin Bio Description and Business Overview
 Table 107. Shuanglin Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shuanglin Bio Rabies Immunoglobulins Product
 Table 109. Shuanglin Bio Recent Developments/Updates
 Table 110. Weiguang Bio Company Information
 Table 111. Weiguang Bio Description and Business Overview
 Table 112. Weiguang Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Weiguang Bio Rabies Immunoglobulins Product
 Table 114. Weiguang Bio Recent Developments/Updates
 Table 115. Shanghai RAAS Company Information
 Table 116. Shanghai RAAS Description and Business Overview
 Table 117. Shanghai RAAS Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai RAAS Rabies Immunoglobulins Product
 Table 119. Shanghai RAAS Recent Developments/Updates
 Table 120. Bharat Serum Company Information
 Table 121. Bharat Serum Description and Business Overview
 Table 122. Bharat Serum Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Bharat Serum Rabies Immunoglobulins Product
 Table 124. Bharat Serum Recent Developments/Updates
 Table 125. VINS Company Information
 Table 126. VINS Description and Business Overview
 Table 127. VINS Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. VINS Rabies Immunoglobulins Product
 Table 129. VINS Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Rabies Immunoglobulins Distributors List
 Table 133. Rabies Immunoglobulins Customers List
 Table 134. Rabies Immunoglobulins Market Trends
 Table 135. Rabies Immunoglobulins Market Drivers
 Table 136. Rabies Immunoglobulins Market Challenges
 Table 137. Rabies Immunoglobulins Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rabies Immunoglobulins
 Figure 2. Global Rabies Immunoglobulins Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rabies Immunoglobulins Market Share by Type: 2024 & 2031
 Figure 4. ERIG Product Picture
 Figure 5. HRIG Product Picture
 Figure 6. Global Rabies Immunoglobulins Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rabies Immunoglobulins Market Share by Application: 2024 & 2031
 Figure 8. Category II Exposure
 Figure 9. Category III Exposure
 Figure 10. Global Rabies Immunoglobulins Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Rabies Immunoglobulins Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Rabies Immunoglobulins Sales (2020-2031) & (M Units)
 Figure 13. Global Rabies Immunoglobulins Average Price (US$/Unit) & (2020-2031)
 Figure 14. Rabies Immunoglobulins Report Years Considered
 Figure 15. Rabies Immunoglobulins Sales Share by Manufacturers in 2024
 Figure 16. Global Rabies Immunoglobulins Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Rabies Immunoglobulins Players: Market Share by Revenue in Rabies Immunoglobulins in 2024
 Figure 18. Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Rabies Immunoglobulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Rabies Immunoglobulins Sales Market Share by Country (2020-2031)
 Figure 21. North America Rabies Immunoglobulins Revenue Market Share by Country (2020-2031)
 Figure 22. United States Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Rabies Immunoglobulins Sales Market Share by Country (2020-2031)
 Figure 25. Europe Rabies Immunoglobulins Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Rabies Immunoglobulins Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Rabies Immunoglobulins Revenue Market Share by Region (2020-2031)
 Figure 33. China Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Rabies Immunoglobulins Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Rabies Immunoglobulins Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Rabies Immunoglobulins Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Rabies Immunoglobulins Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Rabies Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Rabies Immunoglobulins by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Rabies Immunoglobulins by Type (2020-2031)
 Figure 54. Global Rabies Immunoglobulins Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Rabies Immunoglobulins by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Rabies Immunoglobulins by Application (2020-2031)
 Figure 57. Global Rabies Immunoglobulins Price (US$/Unit) by Application (2020-2031)
 Figure 58. Rabies Immunoglobulins Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Rabies Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Immunoglobulin IM Market Research Report 2025
Rabies Immune Globulin Equine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Immune Globulin HRIG Market Research Report 2024
Global Human Rabies Vaccine Market Research Report 2024
Global Equine Rabies Immunoglobulin ERIG Market Research Report 2024
Global Rabies Monoclonal Antibody Market Research Report 2024
Global Passive Immunizing Drugs against Rabies Market Research Report 2024
Global Human Rabies Vaccination Market Research Report 2025
Global Rabies Vaccination Market Research Report 2025
Global Rabies Virus Monoclonal Antibody Market Research Report 2024
Rabies Vaccine Market
Global Rabies Vaccine for Pets Market Research Report 2024
Global Rabies Antiserum Market Research Report 2024
Global Snake Antivenom Immunoglobulin Market Research Report 2024
Rabies Immune Globulin Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RABV G Inhibitors Market Research Report 2024
Global Animal Anti Rabies Vaccine Market Research Report 2024
Global Antivenom Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions